Department of Pathology News

Repairing nerve cell damage from multiple sclerosis

Tuesday, June 17, 2014

Dr. Bridget-Shafit Zagardo investigates how to repair nerve cell damage from multiple sclerosis.

















Each year multiple sclerosis (MS) strikes millions of young adults in the United States and worldwide, limiting their mobility, causing disability and pain, and seriously affecting their quality of life. Onset is observed in young adults in their 20's and 30's, with a pediatric form of MS becoming increasingly prevalent. While various current treatments delay progression or manage the symptoms, there is currently no cure and there is significant decline over a 15-20 year period with a large number of patients progressing from a relapsing remitting disease course to a progressive disease course.

For over 30 years, Einstein Pathology researcher Bridget Shafit-Zagardo, PhD, has worked to understand MS and give people suffering from the neurological disease hope.

“We’re predominantly interested in enhancing repair and functional recovery following central nervous system (CNS) injury,” said Dr. Shafit-Zagardo, a professor of pathology, who joined Einstein in 1984.



Enhancing repair



She explained that MS damages neurons, or nerve cells, and the myelin sheath - the insulation that surrounds and protects axons. The loss of myelin – demyelination - interferes with the transmission of normal nerve conductance required for nerves to signal between the brain, spinal cord and the rest of the body. 

“The goal is to repair axonal damage and enhance remyelination,” she said, noting that the current treatments address inflammation, but do not address nerve cell repair.

The exact antigen — or target that the immune cells are sensitized to attack — remains unknown, which is why MS is considered by many experts to be "immune-mediated," she said.

Abnormally hyper-activated infiltrating immune cells cross the blood brain barrier and induce inflammation in the CNS. As a result, resident cells of the CNS become activated and secrete inflammatory molecules that further enhance inflammation resulting in damage to neurons and oligodendrocytes, the myelin-synthesizing cells of the CNS. Axonal damage, destruction of myelin and activation of astrocytes called astrogliosis, ultimately result in CNS lesions referred to as glial scars or plaques in areas of damage. The resulting insult affects nerve fibers producing symptoms that may affect vision, coordination and mobility, and continence, among other symptoms.  

To that end, Dr. Shafit-Zagardo and her team are investigating strategies to slow the progression of axonal damage and demyelination and to enhance remyelination.

“Until damaged myelin and cell debris resulting from inflammation are cleared, you do not have efficient repair and recovery cannot occur,” said Dr. Shafit-Zagardo. The lab’s ongoing projects include applying techniques of molecular & cell biology, biochemistry, immunocytochemistry, confocal and electron microscopy to address questions concerning the structure, function and regulation of myelination in the normal CNS and remyelination following neuroimmune injury.



Identifying signaling pathways



Central to the treatment of MS is how cell signaling pathways regulate oligodendrocyte cell survival and remyelination after the inflammatory response.
Toward this goal, the lab has used molecular approaches to identify several genes implicated in signaling pathways that regulate oligodendrocytes and protect against demyelination. Among those genes identified were members of the Tyro3/Axl/Mer (TAM) family of receptor tyrosine kinases. As Dr. Shafit-Zagardo explained, to clear debris in MS lesions, the ligand or growth factor binds to receptors on the cell and signals downstream, recruiting signaling molecules that are protective for survival of the cell and also serve to activate other signaling pathways necessary for repair. The lab has demonstrated that signaling through the growth arrest-specific protein 6 (Gas6)/TAM pathway protects oligodendrocytes against injury.

Dr. Shafit-Zagardo’s research is funded by grants from the National Multiple Sclerosis Society and the National Institute of Neurological Disorders and Stroke. Assisting Dr. Shafit-Zagardo in her research is postdoctoral fellow Ross Gruber, graduate student Alex Ray and technician Kathleen O’Guin. Ross and Alex have been generating different mouse models, including single and double knockout mice that can be used to study different signaling pathways.



Moving forward



Despite her many achievements both inside and outside of science, the Bronx native has not had to venture far. After earning her master’s degree in biology at New York University, she studied human genetics with Dr. Robert Desnick and was awarded a PhD from City University of New York/ Mount Sinai School of Medicine, where her research focused on lysosomal storage diseases focusing on Gaucher’s disease. She initially joined Einstein as a postdoctoral research fellow under the mentorship of Dr. Joseph Maio in Cell Biology, working on long interspersed repetitive sequences. Dr. Shafit-Zagardo became involved in MS after seeing that early developmental genes could be turned back on during remyelination, and continued to expand on those initial studies.

MS research has come a long way in the last two decades. “Thirty years ago, there were no real treatments,” Dr. Shafit-Zagardo said, noting that the last 20 years has seen a variety of medications used for MS to block inflammation, but they do not target myelin repair.

Moving forward, her lab will continue to work toward developing better treatment and attempt to attempt to find factors that can aid in repair. She said, “Once we’ve determined how signaling occurs we will be able to use this information to protect against further damage."





Recent News 

  

NYC Viral Hepatitis Research Symposium 

Two-Year Clinical Molecular Genetics & Cytogenetics Fellowship Approved  

Features 

mark-suhrlandMark Suhrland, MD, Blogs about See, Test & Treat and the Pathologist’s Expanding Role in Community-Based Healthcare 

 

 

AdamColeTiffanyHeberExciting Changes  to Our Pathology Residency Program! 

 

 

ABaldwinCharting Her Own Course: From Navy Flight Surgeon to First-Year Pathology Resident 

 

kh-rameshBangalore to the Bronx: The Making of a Clinical and Molecular Cytogeneticist 

 

Awards, Honors & Appointments

moshe-sadofsky Moshe Sadofsky, MD, PhD, receives two prestigious excellence-in-teaching awards.   

Dr. Sadofsky has been selected as the 2018 recipient of the Harry Eagle Award for Outstanding Basic Science Teaching. The faculty-nominated award recognizes a faculty member who is an outstanding teacher and leader in basic science education for Einstein medical students.  Read More 

 

amanda-beck Amanda Beck, DVM, DACVPhas received the American College of Veterinary Pathologists (ACVP) 2017 Samuel W. Thompson Lectureship AwardRead More 

 

kh-ramesh KH Ramesh, PhDwas the keynote speaker at the 5th International Breast Cancer and Pathology Conference, held in Miami, FL, in April. His topic: “Treatment Implications of HER2 Genetic Heterogeneity Detected by FISH Testing of Invasive Ductal Breast Cancer.” Dr. Ramesh was an invited presenter at the 2nd Indian Cancer Congress held in Bangalore, India, in November 2017.  Read More 

 

moshe-sadofskyMoshe Sadofsky, MD, PhD, has been promoted to the rank of Professor of Pathology. 

 


 

DrKarabakhtsianRouzan G. Karabakhtsian, MD,  PhD, has been promoted to the rank of Professor of Pathology.  

 

 

 

 Krasinskir-nelsons-gera 

 

Shweta Gera, MD, Randin Nelson, MD, and Jennifer Oliver-Krasinski, MD attain the rank of Assistant Professor of Pathology.  Read More 

AColantaAngela Colanta, MDjoined the Department of Pathology, Division of Cytology, in April. Dr. Colanta holds a dual appointment as full-time attending physician at Montefiore and Assistant Professor of Pathology at Albert Einstein College of Medicine. Read More 

Nicole AnayannisNicole Anayannis, PhDhas been appointed as a Research Fellow in the laboratory of her mentor, Michael B. Prystowsky, MD, PhD, Professor and University Chair of Pathology at Montefiore Einstein.Read More 

 

Congratulations to Our Newly Minted PhDs and Graduating Residents and Fellows! Click here to view. 

 

Research

Experimental pathology aims to define disease in terms of fundamental molecular and cellular processes. Research in our Department is focused on critical issues in multiple disease classes. Areas of focus include 

Research in each of these areas is highly interactive, and the Department strives for a collegial atmosphere in which collaborations can flourish. This effort is conducted through a variety of department-level activities, including regular meetings to discuss work in progress and a departmental retreat at which students, postdoctoral fellows, residents and faculty all have opportunity to present and discuss their research.

Research Funding Program

The Department of Pathology has established a research funding program to encourage residents and fellows to participate in clinical pilot research projects. Up to $2,000 will be awarded per research project, for projects of up to two years in duration.

Research Faculty

Amanda Beck, DVM 

Geoffrey Childs, PhD 

Joan W. Berman, PhD 

Mahalia Desruisseaux, MD, PhD 

Amy Fox, MD  

David Fooksman, PhD  

Rachel Hazan, PhD 

Lawrence Herbst, DVM, PhD 

Huan Huang, MD 

Sunhee C. Lee, MD  

Fernando Macian, MD, PhD 

Maja Oktay, MD, PhD 

Harry Ostrer, MD 

Thomas J. Ow, MD 

Michael B. Prystowsky, MD, PhD 

Moshe Sadofsky, MD, PhD 

Laura Santambrogio, MD, PhD 

Bridget Shafit-Zagardo, PhD 

Herbert Tanowitz, MD 

Louis Weiss, MD 

Upcoming Departmental Events – Mark Your Calendar!

 

Residents & Fellows Class of 2018 Graduation – Weds., June 6;
6:30 p.m. Westchester Country Club, Harrison, NY
Contact Maria DelPonte, Event Coordinator, at mdelpont@montefiore.org 

Pathology Department Annual Retreat – Thurs., June 7
10 a.m. to 4:15 p.m. Marina del Rey, Bronx, NY

Guest Speaker:
Serena Spudich, MD, MA
Professor of Neurology Division Chief, Neurological Infection & Global Neurology
Co-director, Center for Neuroepidemiology & Clinical Neurobiological Research
Yale University
For more information, please contact: Barbara Groszewski, Event Coordinator, at barbara.groszewski@einstein.yu.edu 10

Click here to log in